TY - JOUR PY - 2011 DA - 2011// TI - Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials JO - Lancet VL - 378 UR - https://doi.org/10.1016/S0140-6736(11)60993-8 DO - 10.1016/S0140-6736(11)60993-8 ID - ref1 ER - TY - JOUR PY - 2005 DA - 2005// TI - Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials JO - Lancet VL - 365 UR - https://doi.org/10.1016/S0140-6736(05)66544-0 DO - 10.1016/S0140-6736(05)66544-0 ID - ref2 ER - TY - JOUR AU - Dowsett, M. AU - Smith, I. E. AU - Ebbs, S. R. AU - Dixon, J. M. AU - Skene, A. AU - Griffith, C. AU - Boeddinghaus, I. AU - Salter, J. AU - Detre, S. AU - Hills, M. PY - 2006 DA - 2006// TI - Proliferation and apoptosis as markers of benefit in neoadjuvant endocrine therapy of breast cancer JO - Clin Cancer Res VL - 12 UR - https://doi.org/10.1158/1078-0432.CCR-05-2127 DO - 10.1158/1078-0432.CCR-05-2127 ID - Dowsett2006 ER - TY - JOUR AU - Goss, P. E. AU - Ingle, J. N. AU - Martino, S. AU - Robert, N. J. AU - Muss, H. B. AU - Piccart, M. J. AU - Castiglione, M. AU - Tu, D. AU - Shepherd, L. E. AU - Pritchard, K. I. PY - 2003 DA - 2003// TI - A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer JO - N Engl J Med VL - 349 UR - https://doi.org/10.1056/NEJMoa032312 DO - 10.1056/NEJMoa032312 ID - Goss2003 ER - TY - JOUR AU - Nicholson, R. I. AU - Hutcheson, I. R. AU - Jones, H. E. AU - Hiscox, S. E. AU - Giles, M. AU - Taylor, K. M. AU - Gee, J. M. PY - 2007 DA - 2007// TI - Growth factor signalling in endocrine and anti-growth factor resistant breast cancer JO - Rev Endocr Metab Disord VL - 8 UR - https://doi.org/10.1007/s11154-007-9033-5 DO - 10.1007/s11154-007-9033-5 ID - Nicholson2007 ER - TY - JOUR AU - Knowlden, J. M. AU - Hutcheson, I. R. AU - Jones, H. E. AU - Madden, T. AU - Gee, J. M. AU - Harper, M. E. AU - Barrow, D. AU - Wakeling, A. E. AU - Nicholson, R. I. PY - 2003 DA - 2003// TI - Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells JO - Endocrinology VL - 144 UR - https://doi.org/10.1210/en.2002-220620 DO - 10.1210/en.2002-220620 ID - Knowlden2003 ER - TY - JOUR AU - Hiscox, S. AU - Barrett-Lee, P. AU - Nicholson, R. I. PY - 2011 DA - 2011// TI - Therapeutic targeting of tumor-stroma interactions JO - Expert Opin Ther Targets VL - 15 UR - https://doi.org/10.1517/14728222.2011.561201 DO - 10.1517/14728222.2011.561201 ID - Hiscox2011 ER - TY - JOUR AU - Hiscox, S. AU - Jordan, N. J. AU - Jiang, W. AU - Harper, M. AU - McClelland, R. AU - Smith, C. AU - Nicholson, R. I. PY - 2006 DA - 2006// TI - Chronic exposure to fulvestrant promotes overexpression of the c-Met receptor in breast cancer cells: implications for tumour-stroma interactions JO - Endocr Relat Cancer VL - 13 UR - https://doi.org/10.1677/erc.1.01270 DO - 10.1677/erc.1.01270 ID - Hiscox2006 ER - TY - JOUR AU - Hiscox, S. AU - Jiang, W. G. AU - Obermeier, K. AU - Taylor, K. AU - Morgan, L. AU - Burmi, R. AU - Barrow, D. AU - Nicholson, R. I. PY - 2006 DA - 2006// TI - Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation JO - Int J Cancer VL - 118 UR - https://doi.org/10.1002/ijc.21355 DO - 10.1002/ijc.21355 ID - Hiscox2006 ER - TY - JOUR AU - Ponta, H. AU - Sherman, L. AU - Herrlich, P. A. PY - 2003 DA - 2003// TI - CD44: from adhesion molecules to signalling regulators JO - Nat Rev Mol Cell Biol VL - 4 UR - https://doi.org/10.1038/nrm1004 DO - 10.1038/nrm1004 ID - Ponta2003 ER - TY - JOUR AU - Orian-Rousseau, V. AU - Chen, L. AU - Sleeman, J. P. AU - Herrlich, P. AU - Ponta, H. PY - 2002 DA - 2002// TI - CD44 is required for two consecutive steps in HGF/c-Met signaling JO - Genes Dev VL - 16 UR - https://doi.org/10.1101/gad.242602 DO - 10.1101/gad.242602 ID - Orian-Rousseau2002 ER - TY - JOUR AU - Bourguignon, L. Y. AU - Singleton, P. A. AU - Zhu, H. AU - Zhou, B. PY - 2002 DA - 2002// TI - Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells JO - J Biol Chem VL - 277 UR - https://doi.org/10.1074/jbc.M204320200 DO - 10.1074/jbc.M204320200 ID - Bourguignon2002 ER - TY - JOUR AU - Palyi-Krekk, Z. AU - Barok, M. AU - Kovacs, T. AU - Saya, H. AU - Nagano, O. AU - Szollosi, J. AU - Nagy, P. PY - 2008 DA - 2008// TI - EGFR and ErbB2 are functionally coupled to CD44 and regulate shedding, internalization and motogenic effect of CD44 JO - Cancer Lett VL - 263 UR - https://doi.org/10.1016/j.canlet.2008.01.014 DO - 10.1016/j.canlet.2008.01.014 ID - Palyi-Krekk2008 ER - TY - JOUR AU - Meran, S. AU - Luo, D. D. AU - Simpson, R. AU - Martin, J. AU - Wells, A. AU - Steadman, R. AU - Phillips, A. O. PY - 2011 DA - 2011// TI - Hyaluronan facilitates transforming growth factor-{beta}1 dependent proliferation via CD44 and epidermal growth factor-receptor interaction JO - J Biol Chem VL - 286 UR - https://doi.org/10.1074/jbc.M111.226563 DO - 10.1074/jbc.M111.226563 ID - Meran2011 ER - TY - JOUR AU - Bourguignon, L. Y. AU - Zhu, H. AU - Chu, A. AU - Iida, N. AU - Zhang, L. AU - Hung, M. C. PY - 1997 DA - 1997// TI - Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation JO - J Biol Chem VL - 272 UR - https://doi.org/10.1074/jbc.272.44.27913 DO - 10.1074/jbc.272.44.27913 ID - Bourguignon1997 ER - TY - JOUR AU - Gotte, M. AU - Yip, G. W. PY - 2006 DA - 2006// TI - Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective JO - Cancer Res VL - 66 UR - https://doi.org/10.1158/0008-5472.CAN-06-1464 DO - 10.1158/0008-5472.CAN-06-1464 ID - Gotte2006 ER - TY - JOUR AU - Tamada, M. AU - Nagano, O. AU - Tateyama, S. AU - Ohmura, M. AU - Yae, T. AU - Ishimoto, T. AU - Sugihara, E. AU - Onishi, N. AU - Yamamoto, T. AU - Yanagawa, H. PY - 2012 DA - 2012// TI - Modulation of glucose metabolism by CD44 contributes to antioxidant status and drug resistance in cancer cells JO - Cancer Res VL - 72 UR - https://doi.org/10.1158/0008-5472.CAN-11-3024 DO - 10.1158/0008-5472.CAN-11-3024 ID - Tamada2012 ER - TY - JOUR AU - Wang, Y. C. AU - Yo, Y. T. AU - Lee, H. Y. AU - Liao, Y. P. AU - Chao, T. K. AU - Su, P. H. AU - Lai, H. C. PY - 2012 DA - 2012// TI - ALDH1-bright epithelial ovarian cancer cells are associated with CD44 expression, drug resistance, and poor clinical outcome JO - Am J Pathol VL - 180 UR - https://doi.org/10.1016/j.ajpath.2011.11.015 DO - 10.1016/j.ajpath.2011.11.015 ID - Wang2012 ER - TY - JOUR AU - Auvinen, P. AU - Tammi, R. AU - Parkkinen, J. AU - Tammi, M. AU - Agren, U. AU - Johansson, R. AU - Hirvikoski, P. AU - Eskelinen, M. AU - Kosma, V. M. PY - 2000 DA - 2000// TI - Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival JO - Am J Pathol VL - 156 UR - https://doi.org/10.1016/S0002-9440(10)64757-8 DO - 10.1016/S0002-9440(10)64757-8 ID - Auvinen2000 ER - TY - JOUR AU - Gee, J. M. AU - Robertson, J. F. AU - Gutteridge, E. AU - Ellis, I. O. AU - Pinder, S. E. AU - Rubini, M. AU - Nicholson, R. I. PY - 2005 DA - 2005// TI - Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer JO - Endocr Relat Cancer VL - 12 UR - https://doi.org/10.1677/erc.1.01005 DO - 10.1677/erc.1.01005 ID - Gee2005 ER - TY - JOUR AU - Koumakpayi, I. H. AU - Le Page, C. AU - Delvoye, N. AU - Saad, F. AU - Mes-Masson, A. M. PY - 2011 DA - 2011// TI - Macropinocytosis inhibitors and Arf6 regulate ErbB3 nuclear localization in prostate cancer cells JO - Mol Carcinog VL - 50 UR - https://doi.org/10.1002/mc.20766 DO - 10.1002/mc.20766 ID - Koumakpayi2011 ER - TY - JOUR AU - Andrique, L. AU - Fauvin, D. AU - El Maassarani, M. AU - Colasson, H. AU - Vannier, B. AU - Seite, P. PY - 2012 DA - 2012// TI - ErbB3(80 kDa), a nuclear variant of the ErbB3 receptor, binds to the Cyclin D1 promoter to activate cell proliferation but is negatively controlled by p14ARF JO - Cell Signal VL - 24 UR - https://doi.org/10.1016/j.cellsig.2012.01.002 DO - 10.1016/j.cellsig.2012.01.002 ID - Andrique2012 ER - TY - JOUR AU - Hutcheson, I. R. AU - Knowlden, J. M. AU - Hiscox, S. E. AU - Barrow, D. AU - Gee, J. M. AU - Robertson, J. F. AU - Ellis, I. O. AU - Nicholson, R. I. PY - 2007 DA - 2007// TI - Heregulin beta1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells JO - Breast Cancer Res VL - 9 UR - https://doi.org/10.1186/bcr1754 DO - 10.1186/bcr1754 ID - Hutcheson2007 ER - TY - JOUR AU - Jones, J. T. AU - Akita, R. W. AU - Sliwkowski, M. X. PY - 1999 DA - 1999// TI - Binding specificities and affinities of egf domains for ErbB receptors JO - FEBS Lett VL - 447 UR - https://doi.org/10.1016/S0014-5793(99)00283-5 DO - 10.1016/S0014-5793(99)00283-5 ID - Jones1999 ER - TY - JOUR AU - Franklin, M. C. AU - Carey, K. D. AU - Vajdos, F. F. AU - Leahy, D. J. AU - de Vos, A. M. AU - Sliwkowski, M. X. PY - 2004 DA - 2004// TI - Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex JO - Cancer Cell VL - 5 UR - https://doi.org/10.1016/S1535-6108(04)00083-2 DO - 10.1016/S1535-6108(04)00083-2 ID - Franklin2004 ER - TY - JOUR AU - Toole, B. P. PY - 2004 DA - 2004// TI - Hyaluronan: from extracellular glue to pericellular cue JO - Nat Rev Cancer VL - 4 UR - https://doi.org/10.1038/nrc1391 DO - 10.1038/nrc1391 ID - Toole2004 ER - TY - JOUR AU - Ahmed, M. A. AU - Aleskandarany, M. A. AU - Rakha, E. A. AU - Moustafa, R. Z. AU - Benhasouna, A. AU - Nolan, C. AU - Green, A. R. AU - Ilyas, M. AU - Ellis, I. O. PY - 2011 DA - 2011// TI - A CD44(-)/CD24 (+) phenotype is a poor prognostic marker in early invasive breast cancer JO - Breast Cancer Res Treat VL - 133 UR - https://doi.org/10.1007/s10549-011-1865-8 DO - 10.1007/s10549-011-1865-8 ID - Ahmed2011 ER - TY - JOUR AU - Gee, J. M. AU - Howell, A. AU - Gullick, W. J. AU - Benz, C. C. AU - Sutherland, R. L. AU - Santen, R. J. AU - Martin, L. A. AU - Ciardiello, F. AU - Miller, W. R. AU - Dowsett, M. PY - 2005 DA - 2005// TI - Consensus statement. Workshop on therapeutic resistance in breast cancer: impact of growth factor signalling pathways and implications for future treatment JO - Endocr Relat Cancer VL - 12 UR - https://doi.org/10.1677/erc.1.01054 DO - 10.1677/erc.1.01054 ID - Gee2005 ER - TY - JOUR AU - Hiscox, S. AU - Morgan, L. AU - Green, T. AU - Nicholson, R. I. PY - 2006 DA - 2006// TI - Src as a therapeutic target in anti-hormone/anti-growth factor-resistant breast cancer JO - Endocr Relat Cancer VL - 13 UR - https://doi.org/10.1677/erc.1.01297 DO - 10.1677/erc.1.01297 ID - Hiscox2006 ER - TY - JOUR AU - Ricardo, S. AU - Vieira, A. F. AU - Gerhard, R. AU - Leitao, D. AU - Pinto, R. AU - Cameselle-Teijeiro, J. F. AU - Milanezi, F. AU - Schmitt, F. AU - Paredes, J. PY - 2011 DA - 2011// TI - Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype JO - J Clin Pathol VL - 64 UR - https://doi.org/10.1136/jcp.2011.090456 DO - 10.1136/jcp.2011.090456 ID - Ricardo2011 ER - TY - JOUR AU - Gordin, M. AU - Tesio, M. AU - Cohen, S. AU - Gore, Y. AU - Lantner, F. AU - Leng, L. AU - Bucala, R. AU - Shachar, I. PY - 2010 DA - 2010// TI - c-Met and its ligand hepatocyte growth factor/scatter factor regulate mature B cell survival in a pathway induced by CD74 JO - J Immunol VL - 185 UR - https://doi.org/10.4049/jimmunol.0902566 DO - 10.4049/jimmunol.0902566 ID - Gordin2010 ER - TY - JOUR AU - Singleton, P. A. AU - Salgia, R. AU - Moreno-Vinasco, L. AU - Moitra, J. AU - Sammani, S. AU - Mirzapoiazova, T. AU - Garcia, J. G. PY - 2007 DA - 2007// TI - CD44 regulates hepatocyte growth factor-mediated vascular integrity. Role of c-Met, Tiam1/Rac1, dynamin 2, and cortactin JO - J Biol Chem VL - 282 UR - https://doi.org/10.1074/jbc.M702573200 DO - 10.1074/jbc.M702573200 ID - Singleton2007 ER - TY - JOUR AU - Tremmel, M. AU - Matzke, A. AU - Albrecht, I. AU - Laib, A. M. AU - Olaku, V. AU - Ballmer-Hofer, K. AU - Christofori, G. AU - Heroult, M. AU - Augustin, H. G. AU - Ponta, H. AU - Orian-Rousseau, V. PY - 2009 DA - 2009// TI - A CD44v6 peptide reveals a role of CD44 in VEGFR-2 signaling and angiogenesis JO - Blood VL - 114 UR - https://doi.org/10.1182/blood-2009-04-219204 DO - 10.1182/blood-2009-04-219204 ID - Tremmel2009 ER - TY - JOUR AU - Bourguignon, L. Y. AU - Zhu, H. AU - Zhou, B. AU - Diedrich, F. AU - Singleton, P. A. AU - Hung, M. C. PY - 2001 DA - 2001// TI - Hyaluronan promotes CD44v3-Vav2 interaction with Grb2-p185(HER2) and induces Rac1 and Ras signaling during ovarian tumor cell migration and growth JO - J Biol Chem VL - 276 UR - https://doi.org/10.1074/jbc.M106759200 DO - 10.1074/jbc.M106759200 ID - Bourguignon2001 ER - TY - JOUR AU - Hatano, H. AU - Shigeishi, H. AU - Kudo, Y. AU - Higashikawa, K. AU - Tobiume, K. AU - Takata, T. AU - Kamata, N. PY - 2011 DA - 2011// TI - RHAMM/ERK interaction induces proliferative activities of cementifying fibroma cells through a mechanism based on the CD44-EGFR JO - Lab Invest VL - 91 UR - https://doi.org/10.1038/labinvest.2010.176 DO - 10.1038/labinvest.2010.176 ID - Hatano2011 ER - TY - JOUR AU - Hiscox, S. AU - Morgan, L. AU - Barrow, D. AU - Dutkowskil, C. AU - Wakeling, A. AU - Nicholson, R. I. PY - 2004 DA - 2004// TI - Tamoxifen resistance in breast cancer cells is accompanied by an enhanced motile and invasive phenotype: inhibition by gefitinib ('Iressa', ZD1839) JO - Clin Exp Metastasis VL - 21 UR - https://doi.org/10.1023/B:CLIN.0000037697.76011.1d DO - 10.1023/B:CLIN.0000037697.76011.1d ID - Hiscox2004 ER - TY - JOUR AU - Zhao, Y. AU - Planas-Silva, M. D. PY - 2009 DA - 2009// TI - Mislocalization of cell-cell adhesion complexes in tamoxifen-resistant breast cancer cells with elevated c-Src tyrosine kinase activity JO - Cancer Lett VL - 275 UR - https://doi.org/10.1016/j.canlet.2008.10.022 DO - 10.1016/j.canlet.2008.10.022 ID - Zhao2009 ER - TY - JOUR AU - Soni, S. AU - Lin, B. T. AU - August, A. AU - Nicholson, R. I. AU - Kirsch, K. H. PY - 2009 DA - 2009// TI - Expression of a phosphorylated p130(Cas) substrate domain attenuates the phosphatidylinositol 3-kinase/Akt survival pathway in tamoxifen resistant breast cancer cells JO - J Cell Biochem VL - 107 UR - https://doi.org/10.1002/jcb.22136 DO - 10.1002/jcb.22136 ID - Soni2009 ER - TY - JOUR AU - Bourguignon, L. Y. AU - Gilad, E. AU - Peyrollier, K. PY - 2007 DA - 2007// TI - Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration JO - J Biol Chem VL - 282 UR - https://doi.org/10.1074/jbc.M610054200 DO - 10.1074/jbc.M610054200 ID - Bourguignon2007 ER - TY - JOUR AU - Sadlonova, A. AU - Bowe, D. B. AU - Novak, Z. AU - Mukherjee, S. AU - Duncan, V. E. AU - Page, G. P. AU - Frost, A. R. PY - 2009 DA - 2009// TI - Identification of molecular distinctions between normal breast-associated fibroblasts and breast cancer-associated fibroblasts JO - Cancer Microenviron VL - 2 UR - https://doi.org/10.1007/s12307-008-0017-0 DO - 10.1007/s12307-008-0017-0 ID - Sadlonova2009 ER - TY - JOUR AU - Cho, S. J. AU - Chae, M. J. AU - Shin, B. K. AU - Kim, H. K. AU - Kim, A. PY - 2008 DA - 2008// TI - Akt- and MAPK-mediated activation and secretion of MMP-9 into stroma in breast cancer cells upon heregulin treatment JO - Mol Med Report VL - 1 ID - Cho2008 ER - TY - JOUR AU - Normanno, N. AU - Kim, N. AU - Wen, D. AU - Smith, K. AU - Harris, A. L. AU - Plowman, G. AU - Colletta, G. AU - Ciardiello, F. AU - Salomon, D. S. PY - 1995 DA - 1995// TI - Expression of messenger RNA for amphiregulin, heregulin, and cripto-1, three new members of the epidermal growth factor family, in human breast carcinomas JO - Breast Cancer Res Treat VL - 35 UR - https://doi.org/10.1007/BF00665981 DO - 10.1007/BF00665981 ID - Normanno1995 ER - TY - JOUR AU - Hudelist, G. AU - Singer, C. F. AU - Manavi, M. AU - Pischinger, K. AU - Kubista, E. AU - Czerwenka, K. PY - 2003 DA - 2003// TI - Co-expression of ErbB-family members in human breast cancer: Her-2/neu is the preferred dimerization candidate in nodal-positive tumors JO - Breast Cancer Res Treat VL - 80 UR - https://doi.org/10.1023/A:1024929522376 DO - 10.1023/A:1024929522376 ID - Hudelist2003 ER - TY - JOUR AU - Visscher, D. W. AU - Sarkar, F. H. AU - Kasunic, T. C. AU - Reddy, K. B. PY - 1997 DA - 1997// TI - Clinicopathologic analysis of amphiregulin and heregulin immunostaining in breast neoplasia JO - Breast Cancer Res Treat VL - 45 UR - https://doi.org/10.1023/A:1005845512804 DO - 10.1023/A:1005845512804 ID - Visscher1997 ER - TY - JOUR AU - Van Phuc, P. AU - Nhan, P. L. AU - Nhung, T. H. AU - Tam, N. T. AU - Hoang, N. M. AU - Tue, V. G. AU - Thuy, D. T. AU - Ngoc, P. K. PY - 2011 DA - 2011// TI - Downregulation of CD44 reduces doxorubicin resistance of CD44CD24 breast cancer cells JO - Onco Targets Ther VL - 4 UR - https://doi.org/10.2147/OTT.S21431 DO - 10.2147/OTT.S21431 ID - Van Phuc2011 ER - TY - JOUR AU - Cain, J. W. AU - Hauptschein, R. S. AU - Stewart, J. K. AU - Bagci, T. AU - Sahagian, G. G. AU - Jay, D. G. PY - 2011 DA - 2011// TI - Identification of CD44 as a Surface Biomarker for Drug Resistance by Surface Proteome Signature Technology JO - Mol Cancer Res VL - 9 UR - https://doi.org/10.1158/1541-7786.MCR-09-0237 DO - 10.1158/1541-7786.MCR-09-0237 ID - Cain2011 ER - TY - JOUR AU - Bourguignon, L. Y. PY - 2008 DA - 2008// TI - Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression JO - Semin Cancer Biol VL - 18 UR - https://doi.org/10.1016/j.semcancer.2008.03.007 DO - 10.1016/j.semcancer.2008.03.007 ID - Bourguignon2008 ER - TY - JOUR AU - Peng, S. T. AU - Su, C. H. AU - Kuo, C. C. AU - Shaw, C. F. AU - Wang, H. S. PY - 2007 DA - 2007// TI - CD44 crosslinking-mediated matrix metalloproteinase-9 relocation in breast tumor cells leads to enhanced metastasis JO - Int J Oncol VL - 31 ID - Peng2007 ER - TY - JOUR AU - Urakawa, H. AU - Nishida, Y. AU - Wasa, J. AU - Arai, E. AU - Zhuo, L. AU - Kimata, K. AU - Kozawa, E. AU - Futamura, N. AU - Ishiguro, N. PY - 2011 DA - 2011// TI - Inhibition of hyaluronan synthesis in breast cancer cells by 4-methylumbelliferone suppresses tumorigenicity in vitro and metastatic lesions of bone in vivo JO - Int J Cancer VL - 30 ID - Urakawa2011 ER - TY - JOUR AU - Hosono, K. AU - Nishida, Y. AU - Knudson, W. AU - Knudson, C. B. AU - Naruse, T. AU - Suzuki, Y. AU - Ishiguro, N. PY - 2007 DA - 2007// TI - Hyaluronan oligosaccharides inhibit tumorigenicity of osteosarcoma cell lines MG-63 and LM-8 in vitro and in vivo via perturbation of hyaluronan-rich pericellular matrix of the cells JO - Am J Pathol VL - 171 UR - https://doi.org/10.2353/ajpath.2007.060828 DO - 10.2353/ajpath.2007.060828 ID - Hosono2007 ER - TY - JOUR AU - Udabage, L. AU - Brownlee, G. R. AU - Waltham, M. AU - Blick, T. AU - Walker, E. C. AU - Heldin, P. AU - Nilsson, S. K. AU - Thompson, E. W. AU - Brown, T. J. PY - 2005 DA - 2005// TI - Antisense-mediated suppression of hyaluronan synthase 2 inhibits the tumorigenesis and progression of breast cancer JO - Cancer Res VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-04-1622 DO - 10.1158/0008-5472.CAN-04-1622 ID - Udabage2005 ER - TY - JOUR AU - Toole, B. P. PY - 2009 DA - 2009// TI - Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-09-0479 DO - 10.1158/1078-0432.CCR-09-0479 ID - Toole2009 ER - TY - JOUR AU - Wallach-Dayan, S. B. AU - Rubinstein, A. M. AU - Hand, C. AU - Breuer, R. AU - Naor, D. PY - 2008 DA - 2008// TI - DNA vaccination with CD44 variant isoform reduces mammary tumor local growth and lung metastasis JO - Mol Cancer Ther VL - 7 UR - https://doi.org/10.1158/1535-7163.MCT-07-2383 DO - 10.1158/1535-7163.MCT-07-2383 ID - Wallach-Dayan2008 ER - TY - JOUR AU - Ma, W. AU - Deng, Y. AU - Zhou, L. PY - 2005 DA - 2005// TI - The prognostic value of adhesion molecule CD44v6 in women with primary breast carcinoma: a clinicopathologic study JO - Clin Oncol (R Coll Radiol) VL - 17 UR - https://doi.org/10.1016/j.clon.2005.02.007 DO - 10.1016/j.clon.2005.02.007 ID - Ma2005 ER - TY - JOUR AU - Diaz, L. K. AU - Zhou, X. AU - Wright, E. T. AU - Cristofanilli, M. AU - Smith, T. AU - Yang, Y. AU - Sneige, N. AU - Sahin, A. AU - Gilcrease, M. Z. PY - 2005 DA - 2005// TI - CD44 expression is associated with increased survival in node-negative invasive breast carcinoma JO - Clin Cancer Res VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-04-2184 DO - 10.1158/1078-0432.CCR-04-2184 ID - Diaz2005 ER - TY - JOUR AU - Afify, A. AU - Purnell, P. AU - Nguyen, L. PY - 2009 DA - 2009// TI - Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion JO - Exp Mol Pathol VL - 86 UR - https://doi.org/10.1016/j.yexmp.2008.12.003 DO - 10.1016/j.yexmp.2008.12.003 ID - Afify2009 ER - TY - JOUR AU - Ouhtit, A. PY - 2007 DA - 2007// TI - Abd Elmageed ZY, Abdraboh ME, Lioe TF, Raj MH: In vivo evidence for the role of CD44s in promoting breast cancer metastasis to the liver JO - Am J Pathol VL - 171 UR - https://doi.org/10.2353/ajpath.2007.070535 DO - 10.2353/ajpath.2007.070535 ID - Ouhtit2007 ER - TY - JOUR AU - Brown, R. L. AU - Reinke, L. M. AU - Damerow, M. S. AU - Perez, D. AU - Chodosh, L. A. AU - Yang, J. AU - Cheng, C. PY - 2011 DA - 2011// TI - CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression JO - J Clin Invest VL - 121 UR - https://doi.org/10.1172/JCI44540 DO - 10.1172/JCI44540 ID - Brown2011 ER - TY - JOUR AU - Afify, A. M. AU - Tate, S. AU - Durbin-Johnson, B. AU - Rocke, D. M. AU - Konia, T. PY - 2011 DA - 2011// TI - Expression of CD44s and CD44v6 in lung cancer and their correlation with prognostic factors JO - Int J Biol Markers VL - 26 UR - https://doi.org/10.5301/JBM.2011.6291 DO - 10.5301/JBM.2011.6291 ID - Afify2011 ER - TY - JOUR AU - Neame, S. J. AU - Isacke, C. M. PY - 1993 DA - 1993// TI - The cytoplasmic tail of CD44 is required for basolateral localization in epithelial MDCK cells but does not mediate association with the detergent-insoluble cytoskeleton of fibroblasts JO - J Cell Biol VL - 121 UR - https://doi.org/10.1083/jcb.121.6.1299 DO - 10.1083/jcb.121.6.1299 ID - Neame1993 ER - TY - JOUR AU - Morgan, L. AU - Gee, J. AU - Pumford, S. AU - Farrow, L. AU - Finlay, P. AU - Robertson, J. AU - Ellis, I. AU - Kawakatsu, H. AU - Nicholson, R. AU - Hiscox, S. PY - 2009 DA - 2009// TI - Elevated Src kinase activity attenuates Tamoxifen response in vitro and is associated with poor prognosis clinically JO - Cancer Biol Ther VL - 8 UR - https://doi.org/10.4161/cbt.8.16.8954 DO - 10.4161/cbt.8.16.8954 ID - Morgan2009 ER - TY - JOUR AU - Gee, J. M. AU - Robertson, J. F. AU - Ellis, I. O. AU - Willsher, P. AU - McClelland, R. A. AU - Hoyle, H. B. AU - Kyme, S. R. AU - Finlay, P. AU - Blamey, R. W. AU - Nicholson, R. I. PY - 1994 DA - 1994// TI - Immunocytochemical localization of BCL-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy JO - Int J Cancer VL - 59 UR - https://doi.org/10.1002/ijc.2910590508 DO - 10.1002/ijc.2910590508 ID - Gee1994 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/12/458/prepub UR - http://www.biomedcentral.com/1471-2407/12/458/prepub ID - ref63 ER -